|
|
Volumn 87, Issue 4 SUPPL. 1, 2001, Pages 21-26
|
|
Laboratory surrogates for anti-atherosclerotic drug development
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTEIN C;
AMYLOID A PROTEIN;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN B;
APOLIPOPROTEIN C3;
BIOLOGICAL MARKER;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 7;
BLOOD CLOTTING FACTOR 9;
C REACTIVE PROTEIN;
D DIMER;
ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1;
FIBRINOGEN;
FIBRINOPEPTIDE A;
GELATINASE A;
GELATINASE B;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HOMOCYSTEINE;
INTERLEUKIN 6;
INTERSTITIAL COLLAGENASE;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLASMINOGEN ACTIVATOR INHIBITOR;
STROMELYSIN;
THROMBIN ANTITHROMBIN COMPLEX;
TISSUE PLASMINOGEN ACTIVATOR;
TUMOR NECROSIS FACTOR ALPHA;
VASCULAR CELL ADHESION MOLECULE 1;
ACTIVATED PROTEIN C RESISTANCE;
ATHEROGENESIS;
BLOOD CLOT LYSIS;
BLOOD CLOTTING;
CARDIOVASCULAR RISK;
COMPARATIVE STUDY;
CORONARY ARTERY ATHEROSCLEROSIS;
DISEASE MARKER;
FIBRINOGEN BLOOD LEVEL;
FIBRINOLYSIS;
HUMAN;
LIPID BLOOD LEVEL;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
REVIEW;
|
|
EID: 0035895631
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)01421-7 Document Type: Article |
|
Times cited : (18)
|
|
References (11)
|
